The American pharmacist has informed the withdrawal of the batches of his treatment against smoking, Chantix, due to the existence of carcinogenic substances called nitrosamines in the pills. The medication is marketed in Europe as Champix.
The pharmaceutical had already paralyzed the distribution of the medication in June to test and now it is already withdrawing the lots from the market. Pfizer has also asked wholesalers and distributors to stop using and distribute that drug "immediately".
However, the company has called calm and has clarified that the intake of this medication does not cause short-term effects on the patient organism treated with it.
Chantix was approved by the FDA in May 2006 as a prescribed medication to help adults over 18 years of age to quit smoking and is generally used for 12 to 24 weeks. On January 1, 2020, it was approved that the National Health System of Spain included between its Public Financing medications the Champix.
Date Of Update: 21 September 2021, 17:48
